Tenecteplase for Late-Window Stroke Guided by DWI-FLAIR Mismatch

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 564 participants.

Also called NCT07540416

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 564 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07540416
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07540416. Randomized; quadruple masking; primary purpose treatment. Start 2026-11-02 (anticipated); primary completion 2028-02-29 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Tenecteplase for Late-Window Stroke Guided by DWI-FLAIR Mismatch
Acronym
TRUST-MISMATCH
Condition
Acute Ischemic Stroke
Intervention (Drug)
TNK-tPA
Intervention (Drug)
Aspirin
Intervention (Drug)
Placebo
Intervention (Drug)
Placebo
Lead sponsor
The First Affiliated Hospital of Zhengzhou University (class: other)

Record details

Record id
cardio:ct-nct07540416
Content hash
f0b2ef128408707b8152fd3e689801db2a5ab90f7233fd01825c831f78e54980